請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6403
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 高淑芬 | |
dc.contributor.author | Chi-Yung Shang | en |
dc.contributor.author | 商志雍 | zh_TW |
dc.date.accessioned | 2021-05-16T16:28:21Z | - |
dc.date.available | 2018-03-04 | |
dc.date.available | 2021-05-16T16:28:21Z | - |
dc.date.copyright | 2013-03-04 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-01-15 | |
dc.identifier.citation | Abrahams, S., Morris, R. G., Polkey, C. E., Jarosz, J. M., Cox, T. C., Graves, M., et al. (1999). Hippocampal involvement in spatial and working memory: a structural MRI analysis of patients with unilateral mesial temporal lobe sclerosis. Brain Cogn, 41(1), 39-65.
Alarcon, M., Plomin, R., Fulker, D. W., Corley, R., & DeFries, J. C. (1998). Multivariate path analysis of specific cognitive abilities data at 12 years of age in the Colorado Adoption Project. Behavior Genetics, 28(4), 255-264. Alberts-Corush, J., Firestone, P., & Goodman, J. T. (1986). Attention and impulsivity characteristics of the biological and adoptive parents of hyperactive and normal control children. Am J Orthopsychiatry, 56(3), 413-423. Allen, A. J., Kurlan, R. M., Gilbert, D. L., Coffey, B. J., Linder, S. L., Lewis, D. W., et al. (2005). Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology, 65(12), 1941-1949. Arnsten, A. F. (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs, 23 Suppl 1, 33-41. Arnsten, A. F., & Li, B. M. (2005). Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry, 57(11), 1377-1384. Arnsten, A. F. T., & Li, B.-M. (2005). Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biological Psychiatry, 57(11), 1377-1384. Asarnow, R. F., Nuechterlein, K. H., Subotnik, K. L., Fogelson, D. L., Torquato, R. D., Payne, D. L., et al. (2002). Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family Study. Arch Gen Psychiatry, 59(11), 1053-1060. Asherson, P., Brookes, K., Franke, B., Chen, W., Gill, M., Ebstein, R. P., et al. (2007). Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry, 164(4), 674-677. Ashtari, M., Kumra, S., Bhaskar, S. L., Clarke, T., Thaden, E., Cervellione, K. L., et al. (2005). Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol Psychiatry, 57(5), 448-455. Baehne, C. G., Ehlis, A. C., Plichta, M. M., Conzelmann, A., Pauli, P., Jacob, C., et al. (2009). Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals. Mol Psychiatry, 14(11), 1032-1039. Bangs, M. E., Hazell, P., Danckaerts, M., Hoare, P., Coghill, D. R., Wehmeier, P. M., et al. (2008). Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics, 121(2), e314-320. Bari, A., Eagle, D. M., Mar, A. C., Robinson, E. S., & Robbins, T. W. (2009). Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology (Berl), 205(2), 273-283. Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull, 121(1), 65-94. Barkley, R. A. (2004). Adolescents with attention-deficit/hyperactivity disorder: an overview of empirically based treatments. J Psychiatr Pract, 10(1), 39-56. Barkley, R. A., Edwards, G., Laneri, M., Fletcher, K., & Metevia, L. (2001). Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). Journal of Abnormal Child Psychology, 29(6), 541-556. Barkley, R. A., Murphy, K. R., Dupaul, G. I., & Bush, T. (2002). Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc, 8(5), 655-672. Barkley, R. A., Smith, K. M., Fischer, M., & Navia, B. (2006). An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet, 141B(5), 487-498. Barnett, R., Maruff, P., & Vance, A. (2005). An investigation of visuospatial memory impairment in children with attention deficit hyperactivity disorder (ADHD), combined type. Psychol Med, 35(10), 1433-1443. Barnett, R., Maruff, P., & Vance, A. (2009). Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders. Australian and New Zealand Journal of Psychiatry, 43(8), 722-730. Barton, J., Mooney, P., & Prasad, S. (2005). Atomoxetine hydrochloride and executive function in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 15(2), 147-149. Beauchamp, M. H., Dagher, A., Aston, J. A., & Doyon, J. (2003). Dynamic functional changes associated with cognitive skill learning of an adapted version of the Tower of London task. Neuroimage, 20(3), 1649-1660. Beaulieu, C. (2002). The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed, 15(7-8), 435-455. Bellgrove, M. A., Chambers, C. D., Johnson, K. A., Daibhis, A., Daly, M., Hawi, Z., et al. (2007). Dopaminergic genotype biases spatial attention in healthy children. Mol Psychiatry, 12(8), 786-792. Berman, T., Douglas, V. I., & Barr, R. G. (1999). Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder. J Abnorm Psychol, 108(1), 90-105. Bertolino, A., Blasi, G., Latorre, V., Rubino, V., Rampino, A., Sinibaldi, L., et al. (2006). Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci, 26(15), 3918-3922. Bertolino, A., Fazio, L., Di Giorgio, A., Blasi, G., Romano, R., Taurisano, P., et al. (2009). Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J Neurosci, 29(4), 1224-1234. Biederman, J., Mick, E., Faraone, S. V., Biederman, J., Mick, E., & Faraone, S. V. (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. American Journal of Psychiatry, 157(5), 816-818. Biederman, J., Monuteaux, M. C., Doyle, A. E., Seidman, L. J., Wilens, T. E., Ferrero, F., et al. (2004). Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. Journal of Consulting & Clinical Psychology, 72(5), 757-766. Biederman, J., Petty, C. R., Ball, S. W., Fried, R., Doyle, A. E., Cohen, D., et al. (2009). Are cognitive deficits in attention deficit/hyperactivity disorder related to the course of the disorder? A prospective controlled follow-up study of grown up boys with persistent and remitting course. Psychiatry Res, 170(2-3), 177-182. Biederman, J., Petty, C. R., Fried, R., Doyle, A. E., Spencer, T., Seidman, L. J., et al. (2007). Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatrica Scandinavica, 116(2), 129-136. Blakemore, S.-J., & Choudhury, S. (2006). Development of the adolescent brain: implications for executive function and social cognition. Journal of Child Psychology & Psychiatry & Allied Disciplines, 47(3-4), 296-312. Blondeau, C., & Dellu-Hagedorn, F. (2007). Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry, 61(12), 1340-1350. Bobb, A. J., Addington, A. M., Sidransky, E., Gornick, M. C., Lerch, J. P., Greenstein, D. K., et al. (2005). Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet, 134B(1), 67-72. Boonstra, A. M., Kooij, J. J., Buitelaar, J. K., Oosterlaan, J., Sergeant, J. A., Heister, J. G., et al. (2008). An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am J Med Genet B Neuropsychiatr Genet, 147(3), 397-402. Brieber, S., Neufang, S., Bruning, N., Kamp-Becker, I., Remschmidt, H., Herpertz-Dahlmann, B., et al. (2007). Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry, 48(12), 1251-1258. Brookes, K., Xu, X., Chen, W., Zhou, K., Neale, B., Lowe, N., et al. (2006). The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry, 11(10), 934-953. Brown, A. B., Biederman, J., Valera, E. M., Doyle, A. E., Bush, G., Spencer, T., et al. (2010). Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet, 153B(2), 365-375. Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K., Threlkeld, P. G., Heiligenstein, J. H., et al. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology, 27(5), 699-711. Caballero, J., & Nahata, M. C. (2003). Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. Clinical Therapeutics, 25(12), 3065-3083. Campbell, H. L., Tivarus, M. E., Hillier, A., & Beversdorf, D. Q. (2008). Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility. Pharmacology, Biochemistry & Behavior, 88(3), 222-229. Campbell, L. E., Daly, E., Toal, F., Stevens, A., Azuma, R., Karmiloff-Smith, A., et al. (2009). Brain structural differences associated with the behavioural phenotype in children with Williams syndrome. Brain Res, 1258, 96-107. Carli, M., Robbins, T. W., Evenden, J. L., & Everitt, B. J. (1983). Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res, 9(3), 361-380. Casey, B. J., Epstein, J. N., Buhle, J., Liston, C., Davidson, M. C., Tonev, S. T., et al. (2007). Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD. Am J Psychiatry, 164(11), 1729-1736. Castellanos, F. X., Giedd, J. N., Berquin, P. C., Walter, J. M., Sharp, W., Tran, T., et al. (2001). Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry, 58(3), 289-295. Castellanos, F. X., Giedd, J. N., Marsh, W. L., Hamburger, S. D., Vaituzis, A. C., Dickstein, D. P., et al. (1996). Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry, 53(7), 607-616. Castellanos, F. X., Lau, E., Tayebi, N., Lee, P., Long, R. E., Giedd, J. N., et al. (1998). Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry, 3(5), 431-434. Castellanos, F. X., Lee, P. P., Sharp, W., Jeffries, N. O., Greenstein, D. K., Clasen, L. S., et al. (2002). Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA, 288(14), 1740-1748. Castellanos, F. X., Sonuga-Barke, E. J., Milham, M. P., & Tannock, R. (2006). Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci, 10(3), 117-123. Castellanos, F. X., Sonuga-Barke, E. J., Scheres, A., Di Martino, A., Hyde, C., & Walters, J. R. (2005). Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biol Psychiatry, 57(11), 1416-1423. Castellanos, F. X., & Tannock, R. (2002). Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci, 3(8), 617-628. Chamberlain, S. R., Del Campo, N., Dowson, J., Muller, U., Clark, L., Robbins, T. W., et al. (2007). Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biological Psychiatry, 62(9), 977-984. Chamberlain, S. R., Hampshire, A., Muller, U., Rubia, K., Del Campo, N., Craig, K., et al. (2009). Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry, 65(7), 550-555. Chamberlain, S. R., Muller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006). Neurochemical modulation of response inhibition and probabilistic learning in humans. Science, 311(5762), 861-863. Chamberlain, S. R., Muller, U., Cleary, S., Robbins, T. W., & Sahakian, B. J. (2007). Atomoxetine increases salivary cortisol in healthy volunteers. J Psychopharmacol, 21(5), 545-549. Chang, C., Crottaz-Herbette, S., & Menon, V. (2007). Temporal dynamics of basal ganglia response and connectivity during verbal working memory. Neuroimage, 34(3), 1253-1269. Chang, H. T., Klorman, R., Shaywitz, S. E., Fletcher, J. M., Marchione, K. E., Holahan, J. M., et al. (1999). Paired-associate learning in attention-deficit/hyperactivity disorder as a function of hyperactivity-impulsivity and oppositional defiant disorder. J Abnorm Child Psychol, 27(3), 237-245. Chen, C. K., Chen, S. L., Mill, J., Huang, Y. S., Lin, S. K., Curran, S., et al. (2003). The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry, 8(4), 393-396. Cheng, J. Y., Chen, R. Y., Ko, J. S., & Ng, E. M. (2007). Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl), 194(2), 197-209. Cheon, K. A., Kim, B. N., & Cho, S. C. (2007). Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children. Neuropsychopharmacology, 32(6), 1377-1383. Cheon, K. A., Ryu, Y. H., Kim, Y. K., Namkoong, K., Kim, C. H., & Lee, J. D. (2003). Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging, 30(2), 306-311. Cheuk, D. K., Li, S. Y., & Wong, V. (2006). No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children. Am J Med Genet B Neuropsychiatr Genet, 141B(2), 123-125. Chiu, C. H., Lo, Y. C., Tang, H. S., Liu, I. C., Chiang, W. Y., Yeh, F. C., et al. (2011). White matter abnormalities of fronto-striato-thalamic circuitry in obsessive-compulsive disorder: A study using diffusion spectrum imaging tractography. Psychiatry Res, 192(3), 176-182. Ciliax, B. J., Drash, G. W., Staley, J. K., Haber, S., Mobley, C. J., Miller, G. W., et al. (1999). Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol, 409(1), 38-56. Clayton, E. C., & Williams, C. L. (2000). Glutamatergic influences on the nucleus paragigantocellularis: contribution to performance in avoidance and spatial memory tasks. Behav Neurosci, 114(4), 707-712. Coghill, D. R., Rhodes, S. M., & Matthews, K. (2007). The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biological Psychiatry, 62(9), 954-962. Cook, E. H., Jr., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., et al. (1995). Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet, 56(4), 993-998. Cornish, K. M., Manly, T., Savage, R., Swanson, J., Morisano, D., Butler, N., et al. (2005). Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry, 10(7), 686-698. Coull, J. T., Frith, C. D., Frackowiak, R. S., & Grasby, P. M. (1996). A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory. Neuropsychologia, 34(11), 1085-1095. Coull, J. T., Jones, M. E., Egan, T. D., Frith, C. D., & Maze, M. (2004). Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans. Neuroimage, 22(1), 315-322. Coull, J. T., Jones, M. E. P., Egan, T. D., Frith, C. D., & Maze, M. (2004). Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans. Neuroimage, 22(1), 315-322. Curtis, C. E., & D'Esposito, M. (2003). Persistent activity in the prefrontal cortex during working memory. Trends Cogn Sci, 7(9), 415-423. De Martino, B., Strange, B. A., & Dolan, R. J. (2008). Noradrenergic neuromodulation of human attention for emotional and neutral stimuli. Psychopharmacology, 197(1), 127-136. Decamp, E., & Schneider, J. S. (2004). Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates. Eur J Neurosci, 20(5), 1371-1378. Depue, R. A., & Collins, P. F. (1999). Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci, 22(3), 491-517; discussion 518-469. Diamond, A. (2007). Consequences of variations in genes that affect dopamine in prefrontal cortex. Cereb Cortex, 17 Suppl 1, i161-170. Dibbets, P., Evers, E. A., Hurks, P. P., Bakker, K., & Jolles, J. (2010). Differential brain activation patterns in adult attention-deficit hyperactivity disorder (ADHD) associated with task switching. Neuropsychology, 24(4), 413-423. Dickstein, S. G., Bannon, K., Castellanos, F. X., & Milham, M. P. (2006). The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry, 47(10), 1051-1062. Diekhof, E. K., Falkai, P., & Gruber, O. (2009). Functional interactions guiding adaptive processing of behavioral significance. Hum Brain Mapp, 30(10), 3325-3331. Dolan, M., & Park, I. (2002). The neuropsychology of antisocial personality disorder. Psychol Med, 32(3), 417-427. Donohoe, G., Morris, D. W., Clarke, S., McGhee, K. A., Schwaiger, S., Nangle, J. M., et al. (2007). Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia, 45(2), 454-458. Downes, J. J., Roberts, A. C., Sahakian, B. J., Evenden, J. L., Morris, R. G., & Robbins, T. W. (1989). Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia, 27(11-12), 1329-1343. Doyle, A. E., Willcutt, E. G., Seidman, L. J., Biederman, J., Chouinard, V. A., Silva, J., et al. (2005). Attention-deficit/hyperactivity disorder endophenotypes. Biological Psychiatry, 57(11), 1324-1335. Dresel, S., Krause, J., Krause, K. H., LaFougere, C., Brinkbaumer, K., Kung, H. F., et al. (2000). Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med, 27(10), 1518-1524. du Boisgueheneuc, F., Levy, R., Volle, E., Seassau, M., Duffau, H., Kinkingnehun, S., et al. (2006). Functions of the left superior frontal gyrus in humans: a lesion study. Brain, 129(Pt 12), 3315-3328. Durston, S. (2010). Imaging genetics in ADHD. Neuroimage, 53(3), 832-838. Durston, S., Fossella, J. A., Casey, B. J., Hulshoff Pol, H. E., Galvan, A., Schnack, H. G., et al. (2005). Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry, 10(7), 678-685. Durston, S., Fossella, J. A., Mulder, M. J., Casey, B. J., Ziermans, T. B., Vessaz, M. N., et al. (2008). Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child Adolesc Psychiatry, 47(1), 61-67. Durston, S., Hulshoff Pol, H. E., Schnack, H. G., Buitelaar, J. K., Steenhuis, M. P., Minderaa, R. B., et al. (2004). Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry, 43(3), 332-340. Durston, S. P. H. D., Hulshoff Pol, H. E. P. H. D., Schnack, H. G. P. H. D., Buitelaar, J. K. M. D. P. H. D., Steenhuis, M. P. M. S., Minderaa, R. B. M. D. P. H. D., et al. (2004). Magnetic Resonance Imaging of Boys With Attention-Deficit/Hyperactivity Disorder and Their Unaffected Siblings. Journal of the American Academy of Child & Adolescent Psychiatry, 43(3), 332-340. Egerhazi, A., Berecz, R., Bartok, E., & Degrell, I. (2007). Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry, 31(3), 746-751. Elliott, R., & Deakin, B. (2005). Role of the orbitofrontal cortex in reinforcement processing and inhibitory control: evidence from functional magnetic resonance imaging studies in healthy human subjects. Int Rev Neurobiol, 65, 89-116. Elliott, R., Frith, C. D., & Dolan, R. J. (1997). Differential neural response to positive and negative feedback in planning and guessing tasks. Neuropsychologia, 35(10), 1395-1404. Elliott, R., Sahakian, B. J., Matthews, K., Bannerjea, A., Rimmer, J., & Robbins, T. W. (1997). Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131(2), 196-206. Epstein, J. N., Conners, C. K., Hervey, A. S., Tonev, S. T., Arnold, L. E., Abikoff, H. B., et al. (2006). Assessing medication effects in the MTA study using neuropsychological outcomes.[see comment]. Journal of Child Psychology & Psychiatry & Allied Disciplines, 47(5), 446-456. Ersche, K. D., Roiser, J. P., Lucas, M., Domenici, E., Robbins, T. W., & Bullmore, E. T. (2011). Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. Psychopharmacology (Berl), 214(4), 779-789. Fan, J., Wu, Y., Fossella, J. A., & Posner, M. I. (2001). Assessing the heritability of attentional networks. BMC Neurosci, 2, 14. Faraone, S. V. (2000). Genetics of childhood disorders: XX. ADHD, Part 4: is ADHD genetically heterogeneous? Journal of the American Academy of Child & Adolescent Psychiatry, 39(11), 1455-1457. Faraone, S. V., Biederman, J., Doyle, A., Murray, K., Petty, C., Adamson, J. J., et al. (2006). Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry, 60(10), 1081-1087. Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., et al. (2005). Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology, 15(4), 664-670. Faraone, S. V., Biederman, J., Spencer, T., Wilens, T., Seidman, L. J., Mick, E., et al. (2000). Attention-deficit/hyperactivity disorder in adults: an overview. Biological Psychiatry, 48(1), 9-20. Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., et al. (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry, 57(11), 1313-1323. Fassbender, C., Zhang, H., Buzy, W. M., Cortes, C. R., Mizuiri, D., Beckett, L., et al. (2009). A lack of default network suppression is linked to increased distractibility in ADHD. Brain Res, 1273, 114-128. Feron, F. J., Hendriksen, J. G., van Kroonenburgh, M. J., Blom-Coenjaerts, C., Kessels, A. G., Jolles, J., et al. (2005). Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate. Pediatr Neurol, 33(3), 179-183. Fischer, M., Barkley, R. A., Edelbrock, C. S., Smallish, L., Fischer, M., Barkley, R. A., et al. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. Journal of Consulting & Clinical Psychology, 58(5), 580-588. Foong, J., Rozewicz, L., Quaghebeur, G., Davie, C. A., Kartsounis, L. D., Thompson, A. J., et al. (1997). Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain, 120 ( Pt 1), 15-26. Friedel, S., Saar, K., Sauer, S., Dempfle, A., Walitza, S., Renner, T., et al. (2007). Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol Psychiatry, 12(10), 923-933. Fuster, J. M. (2002). Frontal lobe and cognitive development. J Neurocytol, 31(3-5), 373-385. Gainetdinov, R. R., & Caron, M. G. (2001). Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD. J Am Acad Child Adolesc Psychiatry, 40(3), 380-382. Gainetdinov, R. R., Jones, S. R., & Caron, M. G. (1999). Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry, 46(3), 303-311. Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science, 283(5400), 397-401. Gau, S. S., Chiu, C. D., Shang, C. Y., Cheng, A. T., & Soong, W. T. (2009). Executive function in adolescence among children with attention-deficit/hyperactivity disorder in Taiwan. J Dev Behav Pediatr, 30(6), 525-534. Gau, S. S., Chong, M. Y., Chen, T. H., & Cheng, A. T. (2005). A 3-year panel study of mental disorders among adolescents in Taiwan. Am J Psychiatry, 162(7), 1344-1350. Gau, S. S., Huang, Y. S., Soong, W. T., Chou, M. C., Chou, W. J., Shang, C. Y., et al. (2007). A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in taiwanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol, 17(4), 447-460. Gau, S. S., Lin, C. H., Hu, F. C., Shang, C. Y., Swanson, J. M., Liu, Y. C., et al. (2009). Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, Version IV Scale-Teacher Form. J Pediatr Psychol, 34(8), 850-861. Gau, S. S., & Shang, C. Y. (2010a). Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB). J Child Psychol Psychiatry, 51(7), 838-849. Gau, S. S., & Shang, C. Y. (2010b). Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine. Int J Neuropsychopharmacol, 13(2), 243-256. Gau, S. S., Shang, C. Y., Liu, S. K., Lin, C. H., Swanson, J. M., Liu, Y. C., et al. (2008). Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale - parent form. Int J Methods Psychiatr Res, 17(1), 35-44. Gau, S. S., Soong, W. T., Chiu, Y. N., & Tsai, W. C. (2006). Psychometric properties of the Chinese version of the Conners' Parent and Teacher Rating Scales-Revised: Short Form. J Atten Disord, 9(4), 648-659. Geller, D., Donnelly, C., Lopez, F., Rubin, R., Newcorn, J., Sutton, V., et al. (2007). Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry, 46(9), 1119-1127. Genro, J. P., Kieling, C., Rohde, L. A., & Hutz, M. H. (2010). Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev Neurother, 10(4), 587-601. Genro, J. P., Polanczyk, G. V., Zeni, C., Oliveira, A. S., Roman, T., Rohde, L. A., et al. (2008). A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet, 147B(8), 1568-1575. Gibbs, M. E. (2008). Memory systems in the chick: regional and temporal control by noradrenaline. Brain Res Bull, 76(3), 170-182. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379(6566), 606-612. Gizer, I. R., Ficks, C., & Waldman, I. D. (2009). Candidate gene studies of ADHD: a meta-analytic review. Hum Genet, 126(1), 51-90. Greenwood, T. A., Alexander, M., Keck, P. E., McElroy, S., Sadovnick, A. D., Remick, R. A., et al. (2002). Segmental linkage disequilibrium within the dopamine transporter gene. Mol Psychiatry, 7(2), 165-173. Greenwood, T. A., & Kelsoe, J. R. (2003). Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics, 82(5), 511-520. Gropper, R. J., & Tannock, R. (2009). A pilot study of working memory and academic achievement in college students with ADHD. J Atten Disord, 12(6), 574-581. Hamilton, L. S., Levitt, J. G., O'Neill, J., Alger, J. R., Luders, E., Phillips, O. R., et al. (2008). Reduced white matter integrity in attention-deficit hyperactivity disorder. Neuroreport, 19(17), 1705-1708. Hampshire, A., & Owen, A. M. (2006). Fractionating attentional control using event-related fMRI. Cereb Cortex, 16(12), 1679-1689. Hand, D. J., Fox, A. T., & Reilly, M. P. (2006). Response acquisition with delayed reinforcement in a rodent model of attention-deficit/hyperactivity disorder (ADHD). Behav Brain Res, 175(2), 337-342. Jahfari, S., Waldorp, L., van den Wildenberg, W. P., Scholte, H. S., Ridderinkhof, K. R., & Forstmann, B. U. (2011). Effective connectivity reveals important roles for both the hyperdirect (fronto-subthalamic) and the indirect (fronto-striatal-pallidal) fronto-basal ganglia pathways during response inhibition. J Neurosci, 31(18), 6891-6899. Johansen-Berg, H., & Behrens, T. E. (2009). Diffusion MRI: From Quantitative Measurement to In-vivo. Neuroanatomy Academic Press, Oxford, UK. Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., & Caron, M. G. (1998). Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci U S A, 95(7), 4029-4034. Karama, S., Grizenko, N., Sonuga-Barke, E., Doyle, A., Biederman, J., Mbekou, V., et al. (2008). Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry, 8, 45. Kates, W. R., Frederikse, M., Mostofsky, S. H., Folley, B. S., Cooper, K., Mazur-Hopkins, P., et al. (2002). MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res, 116(1-2), 63-81. Kehagia, A. A., Murray, G. K., & Robbins, T. W. (2010). Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol, 20(2), 199-204. Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., et al. (2004). Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics, 114(1). Kempton, S., Vance, A., Maruff, P., Luk, E., Costin, J., & Pantelis, C. (1999). Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med, 29(3), 527-538. Kessler, R. C., Adler, L. A., Barkley, R., Biederman, J., Conners, C. K., Faraone, S. V., et al. (2005). Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biological Psychiatry, 57(11), 1442-1451. Kieling, C., Genro, J. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6403 | - |
dc.description.abstract | 注意力不足過動症常合併執行功能障礙,但其他認知功能障礙則較少被研究,另外也沒有研究證實atomoxetine藥物治療可以改善這些認知功能障礙,而這些認知功能障礙潛在的神經構造與基因病因仍未有定論。本博士論文將分成以下四個層面來回答上述問題。
(一)神經心理學方面:(a) 探索53位在兒童期被診斷為ADHD的青少年及53位配對的健康對照組的執行功能,以劍橋神經心理測驗 (Cambridge Neuropsychological Test Automated Battery,CANTAB) 測量其執行功能,結果發現ADHD患者在這四個執行功能測驗表現均較對照組差,證實ADHD青少年患者有顯著的執行功能障礙,並在面對複雜作業時需要額外協助。 (b) 以279位ADHD患者、其未發病手足 (n=108)、及173位健康對照組,探索其執行功能與視覺記憶是否可以成為神經心理學的內表現型。我們使用CANTAB來測量執行功能以及視覺記憶,結果發現ADHD患者和其未發病手足在四個執行功能與四個視覺記憶測驗表現較健康對照組差,未發病手足在兩個視覺記憶測驗的表現介於ADHD和對照組之間,證實執行功能和視覺記憶確實可作為ADHD的神經心理學內表現型。 (二)藥物學方面:以30位8到16歲未曾服用過藥物的ADHD患者,進行一項持續12週開放標籤的atomoxetine藥物試驗,以瞭解其執行功能及視覺記憶在用藥後4週和12週的改善,結果發現患者在服藥後除了臨床表現及社會功能有顯著進步,在所測試的四項執行功能和兩項視覺記憶表現均有明顯進步,顯示atomoxetine可有效改善ADHD患者的執行功能與視覺記憶障礙。 (三)神經影像學方面:以25位ADHD患童及25位在年齡、性別、慣用手、以及智商配對的健康對照組,瞭解額葉紋狀體神經束的完整性以及其和執行功能的相關性。結果發現患者以擴散頻譜造影 (diffusion spectrum imaging,DSI) 重建的兩側各四條額葉紋狀體神經路徑 (背外側、內側、眼窩前額葉、及腹外側) 的一般性之部分異向性 (generalized fractional anisotropy) 值均較對照組低,且和ADHD的症狀嚴重度和執行功能障礙有顯著相關,特別是左側的眼窩前額葉和腹外側等神經纖維束。 (四)基因關聯性方面: (a) 以273位ADHD家族 (n=906) 的DNA在DAT1基因上找出14個單核苷酸多型性 (SNP) 與3´variable number of tandem repeat (VNTR),結果這15個基因標記的LD結構,包含3個單套體區間,第一個區間大小為19kb,位於第二、四、六個內顯子,第二個區間大小為3kb,位於第八、十一個內顯子,第三個區間大小為953bp,位於3´UTR。單套體分析發現rs27048 (C) /rs429699 (T) 與注意力不足亞型有顯著相關,在量性分析上也發現rs27048 (C) /rs429699 (T) 與注意力不足症狀的嚴重度有顯著相關,顯示 DAT1基因在ADHD的注意力不足亞型的病理生理機轉上扮演重要角色。 (b) DAT1基因與執行功能的關聯性:以 382位ADHD家族 (n=1298) 的DNA樣本及其執行功能進行分析。單套體分析發現,第一個單套體區間rs403636 (G) /rs463379 (C) /rs393795 (C) /rs37020 (G) 和空間工作記憶的錯誤量有顯著相關性。顯示DAT1基因在ADHD的空間工作記憶障礙扮演重要角色。 綜合以上研究,本博士研究發現ADHD除了有執行功能的障礙之外,同時是世界上第一個研究證實視覺記憶是內表現型,並且atomoxetine治療可以改善執行功能與視覺記憶障礙,而ADHD的執行功能障礙與額葉紋狀體神經聯結及DAT1基因變異有明顯相關性,未來需要藉由藥物基因學以及影像基因學的研究以建立ADHD的病理生理機轉。 | zh_TW |
dc.description.abstract | Although ADHD is often associated with executive deficits, little research has report other cognitive dysfunction in ADHD. No study has investigated the effect of atomoxetine on the cognitive dysfunction in children with ADHD. In addition, the neural correlates and genetic variants of cognitive dysfunction is still inconclusive. The doctoral thesis will answer these questions from four approaches.
(1) Neuropsychological approach: (a) Using 53 adolescents with childhood diagnosis of ADHD, and 53 matched controls, we examined their EF assessed by using the tasks involving the EF of the CANTAB. The ADHD group performed worse in all the EF tasks, and needed extra assistance while complex tasks were assigned. (b) Using 279 adolescents with ADHD, 108 unaffected siblings and 173 controls, we examined their EF and VM to test whether EF and VM can be potential endophenotypes for ADHD. The ADHD probands and the unaffected siblings significantly performed worse in all the EF tasks. The unaffected siblings occupied an intermediate position between ADHD probands and controls in the performance on two VM tasks, suggesting that EF and VM can be useful endophenotypes for ADHD. (2) Pharmacological approach: we examined the effect of atomoxetine on EF and VM in 30 drug-naïve boys with ADHD, aged 8-16, in an open-label trial after 12-week treatment. In addition to improvement in clinical and social functions, results showed significant improvement in EF and VM after treatment with atomoxetine for 4 weeks or 12 weeks. Our findings suggest that atomoxetine is effective in improving EF and VM among boys with ADHD. (3) Neuroimaging approach: using 25 children with ADHD and 25 matched controls, we examined the association between the integrity of FS tracts and EF. The FS reconstructed by DSI tractography were subdivided into four segments, including dorsolateral, medial prefrontal, orbitofrontal, and ventrolateral tracts. Children with ADHD had lower generalized fractional anisotropy of all the bilateral frontostriatal fiber tracts. ADHD symptom severity and EF performance significantly correlated with integrity of the FS, particularly the left orbitofrontal and ventrolateral tracts. (4) Genetic association approach: (a) we recruited a Chinese family-based sample (n = 906), and screened 15 polymorphisms across the DAT1 gene, including 14 SNPs and the variable number of tandem repeat (VNTR) polymorphism in 3´-untranslated region (3´UTR). Calculations of pairwise LD revealed three main haplotype blocks (HBs). Haplotype analysis showed that a haplotype rs27048 (C) /rs429699 (T) was significantly associated with the inattentive subtype. Our findings indicate that the DAT1 gene may primarily affect the inattentive subtype of ADHD. (b) We extended the family-based sample (n = 1298) and examined the association between DAT1 and EF. Haplotype-based association tests showed that a haplotype rs403636 (G) /rs463379 (C) /rs393795 (C) /rs37020 (G) in HB1 was significantly associated with SWM errors. Our findings indicate that DAT1 plays a role in the SWM errors of ADHD. In summary, in addition to EF, we identified VM as potential endophenotype for ADHD and found significant effects of atomoxetine on EF and VM. We demonstrated that EF was linked to disturbed integrity of frontostriatal tracts and variations of the DAT1 gene. Further pharmacogenetic and imaging genetic studies are needed to establish the pathophysiological pathways underlying ADHD. | en |
dc.description.provenance | Made available in DSpace on 2021-05-16T16:28:21Z (GMT). No. of bitstreams: 1 ntu-102-D96421005-1.pdf: 1923418 bytes, checksum: f2a5d0757c999cdd2f49b91e39e6a8d4 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 目錄
中文摘要..................................................1 英文摘要..................................................3 1. 緒論...................................................5 1.1注意力不足過動症的臨床症狀、診斷、與流行病學研究....5 1.2注意力不足過動症的神經認知功能障礙..................8 1.2.1 神經認知功能障礙..............................8 1.2.2 神經認知內表現型..............................9 1.3注意力不足過動症的內表現型與藥物治療...............11 1.4注意力不足過動症的執行功能障礙與神經影像學.........13 1.5注意力不足過動症的基因遺傳學.......................15 1.5.1 DAT1基因與注意力不足過動症的相關性研究.......15 1.5.2 DAT1基因與執行功能障礙之相關性...............18 1.6研究問題與假說.....................................20 1.6.1注意力不足過動症的執行功能障礙................20 1.6.2注意力不足過動症的內表現型與藥物治療..........22 1.6.3注意力不足過動症的執行功能障礙與神經影像學....23 1.6.4注意力不足過動症的基因遺傳學..................24 2. 研究方法與材料........................................26 2.1注意力不足過動症的神經認知功能障礙.................26 2.1.1 神經認知功能障礙.............................26 2.1.2 神經認知內表現型.............................28 2.2注意力不足過動症的內表現型與藥物治療...............31 2.3注意力不足過動症的執行功能障礙與神經影像學.........32 2.4注意力不足過動症的基因遺傳學.......................35 2.4.1 DAT1基因與注意力不足過動症的相關性研究.......35 2.4.2 DAT1基因與執行功能障礙之相關性...............36 3. 結果..................................................39 3.1注意力不足過動症的神經認知功能障礙.................39 3.1.1 神經認知功能障礙.............................39 3.1.2 神經認知內表現型.............................40 3.2注意力不足過動症的的內表現型與藥物治療.............41 3.3注意力不足過動症的執行功能障礙與神經影像學.........43 3.4注意力不足過動症的基因遺傳學.......................43 3.4.1 DAT1基因與注意力不足過動症的相關性研究.......43 3.4.2 DAT1基因與執行功能障礙之相關性...............44 4. 討論..................................................46 4.1注意力不足過動症的神經認知功能障礙.................48 4.1.1 神經認知功能障礙.............................48 4.1.2 神經認知內表現型.............................50 4.2注意力不足過動症的內表現型與藥物治療...............56 4.3注意力不足過動症的執行功能障礙與神經影像學.........60 4.4注意力不足過動症的基因遺傳學.......................65 4.4.1 DAT1基因與注意力不足過動症的相關性研究.......65 4.4.2 DAT1基因與執行功能障礙之相關性...............67 5. 展望..................................................70 5.1 藥物基因學.......................................................70 5.2 結構性與功能性神經影像學..........................73 5.3 影像基因學........................................75 5.4 動物模式..........................................78 6. 論文英文簡述..........................................80 6.1 Neuropsychological dysfunction in ADHD............80 6.1.1 Neuropsychological dysfunction...............80 6.1.2 Neuropsychological endophenotypes............85 6.2 Neuropsychological endophenotypes and atomoxetine in ADHD................92 6.3 Neuroimaging in ADHD..............................99 6.4 Genetic association studies on ADHD..............105 6.4.1 Association of DAT1 gene and ADHD...........105 6.4.2 Association of DAT1 gene and executive dysfunction in ADHD.......111 7. 參考文獻.............................................119 8. 表與圖...............................................160 9. 附錄.................................................193 9.1修業期間發表之主要論文............................193 9.2修業期間發表之其他論文............................193 | |
dc.language.iso | zh-TW | |
dc.title | 注意力不足過動症之神經生物學與基因學研究 | zh_TW |
dc.title | Neurobiological and Genetic Studies on Attention Deficit Hyperactivity Disorder | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-1 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 楊偉勛 | |
dc.contributor.oralexamcommittee | 曾文毅,陳為堅,陳嘉祥,邱麗珠,藍先元 | |
dc.subject.keyword | 注意力不足過動症,劍橋神經心理測驗,執行功能,視覺記憶,額葉紋狀體神經路徑,擴散頻譜造影,多巴胺轉運基因,單套體,連鎖不平衡, | zh_TW |
dc.subject.keyword | Attention-deficit/hyperactivity disorder (ADHD),frontostriatal tracts (FS),diffusion spectrum imaging (DSI),executive function (EF),visual memory (VM),Cambridge Neuropsychological Test Automated Battery (CANTAB),DAT1,haplotype,linkage disequilibrium (LD), | en |
dc.relation.page | 194 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2013-01-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf | 1.88 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。